Wuhan Hhd Factory Supply Pharmaceutical Intermediate Aviptadil Acetate CAS 40077-57-4

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: HHD
• Certification: Enterprise Standards
• Suitable for: Adult
• State: Powder
• Purity: >98%
• Color: White Powder
• Grade: Pharmaceutical Grade
• Product Name: Aviptadil
• Usage: Cosmetic Raw Materials
• Transport Package: Alumininum Foli Bags
• Specification: 10g, 50g, 200g, 1kg, 5kg
• Trademark: hhdpharm
• Origin: China

Product Description

 

Name	Aviptadil Acetate
CAS No.	40077-57-4
Sequence	HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
Molecular Formula	C147H238N44O42S
Molecular weight	3325.80
Purity	>99%
Appearance	White powder
Storage temp	Freeze dried at -20ºC, protected from light
Synonyms	Vasoactiveintestinal octacosapeptide (pig);Dog VIP octacosapeptide;Human VIP;Human VIP (1-28);L-Aspartamide, L-histidyl-L-seryl-L-a-aspartyl-L-alanyl-L-valyl-L-phenylalanyl-L-threonyl-L-a-aspartyl-L-asparaginyl-L-tyrosyl-L-threonyl-L-arginyl-L-leucyl-L-arginyl-L-lysyl-L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-asparaginyl-L-seryl-L-isoleucyl-L-leucyl-;Mouse VIP;Pig VIP;Pig vasoactive intestinal peptide;Porcine VIP;Porcinevasoactive intestinal peptide;Rat VIP;Rat vasoactive intestinal polypeptide;Sheep VIP;VIP (human);Vasoactive intestinal octacosapeptide (cattle);Vasoactive intestinaloctacosapeptide (goat);Vasoactiveintestinal octacosapeptide (rabbit);Vasoactive intestinal peptide (mouse);Vasoactive intestinal peptide (pig);Vasoactive intestinal peptide (porcine);Vasoactive intestinal polypeptide (human);Vasoactive intestinal polypeptide(rat);VIP, human, ovine, porcine, rat;VIP, human, porcine, rat: VIP (28 amino acids);
Structural formula

What is Aviptadil Acetate?

Aviptadil, also known as vasoactive intestinal polypeptide (VIP), is a 28 amino acid neuropeptide that belongs to the glucagon-growth hormone-releasing factor secretion superfamily. Aviptadil acts as a potent systemic vasodilator and bronchodilator. It inhibits the proliferation of vascular and bronchial smooth muscle cells and decreases platelet aggregation. These biological effects are mediated by specific VIP receptors.